Jian Ming Mei

Jian Ming Mei

Directeur Général chez ANTENGENE CORPORATION LIMITED

Fortune : 90 M $ au 31/07/2026

60 ans
Health Technology
Consumer Services
Commercial Services

Profil

Jian Ming Mei is the founder of Antengene Corp.
Ltd., founded in 2018, serving as Chairman & Chief Executive Officer since its founding.
Current jobs include Member at the American Society of Hematology since 2006.
Former jobs include Executive Director-Clinical Development Department at Celgene Corp.
from 2008 to 2017, Senior Director at Novartis Oncology, Inc. from 2006 to 2008, Associate Director at Johnson & Johnson Pharmaceutical Research & Development LLC from 2001 to 2006, Director at Jiangsu Asieris Pharmaceuticals Co. Ltd. from 2014 to 2020, and Member at the American Society of Clinical Oncology, Inc. Education history includes a doctorate from the University of Maryland conferred in 1994 and a doctorate from Xiangya Hospital Central South University conferred in 1989.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
27/04/2026 178 626 994 ( 26,29% ) 90 M $ 31/07/2026

Postes actifs de Jian Ming Mei

SociétésPosteDébut
ANTENGENE CORPORATION LIMITED Directeur Général 28/08/2018
Corporate Officer/Principal 01/01/2006

Anciens postes connus de Jian Ming Mei

SociétésPosteFin
Jiangsu Asieris Pharmaceuticals Co. Ltd.
Directeur/Membre du Conseil 01/12/2020
CELGENE Directeur Technique/Scientifique/R&D 01/03/2017
Directeur/Membre du Conseil 01/10/2008
Corporate Officer/Principal 01/04/2006
Corporate Officer/Principal -
Voir l'expérience en détail de Jian Ming Mei

Formation de Jian Ming Mei

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

84

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées9

Health Technology

Health Technology

Consumer Services

Commercial Services

Health Services

Commercial Services

Consumer Services

Health Technology

Jiangsu Asieris Pharmaceuticals Co. Ltd.

  1. Bourse
  2. Insiders
  3. Jian Ming Mei